Onconetix, Inc. (ONCO) stock
ONCONasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.00+0.09 (+3.09%)
Close on Nov 17, 2026Market cap $11.85MP/E –Yield –
Onconetix price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Onconetix's price to sales ratio was 22.1× on Nov 11, 2026, against 17.0× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 22.1× | −377.8 |
| 2025 | Jul 31, 2025 | 399.8× | – |
See a number that looks wrong?